EP1032266A4 - Verwendung von delta-5-androsten-3-beta-ol-7,17-dion in der behandlung der arthritis - Google Patents
Verwendung von delta-5-androsten-3-beta-ol-7,17-dion in der behandlung der arthritisInfo
- Publication number
- EP1032266A4 EP1032266A4 EP98958020A EP98958020A EP1032266A4 EP 1032266 A4 EP1032266 A4 EP 1032266A4 EP 98958020 A EP98958020 A EP 98958020A EP 98958020 A EP98958020 A EP 98958020A EP 1032266 A4 EP1032266 A4 EP 1032266A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- delta5
- 3beta
- androstene
- dione
- arthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6619797P | 1997-11-19 | 1997-11-19 | |
US66197P | 1997-11-19 | ||
PCT/US1998/024458 WO1999025192A1 (en) | 1997-11-19 | 1998-11-17 | USE OF Δ5-ANDROSTENE-3β-OL-7,17-DIONE IN THE TREATMENT OF ARTHRITIS |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1032266A1 EP1032266A1 (de) | 2000-09-06 |
EP1032266A4 true EP1032266A4 (de) | 2003-07-16 |
Family
ID=22067899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98958020A Withdrawn EP1032266A4 (de) | 1997-11-19 | 1998-11-17 | Verwendung von delta-5-androsten-3-beta-ol-7,17-dion in der behandlung der arthritis |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1032266A4 (de) |
AU (1) | AU766908B2 (de) |
CA (1) | CA2311471A1 (de) |
WO (1) | WO1999025192A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002043737A1 (en) * | 2000-11-30 | 2002-06-06 | Humanetics Corporation | Treatment of chronic fatigue syndrome and fibromyalgia syndrome |
US6399085B1 (en) | 2001-03-05 | 2002-06-04 | Humanetics Corporation | Method of moisturizing the skin by the topical application of Δ5-androstene-3β-ol-7,17 dione and metabolizable precursors thereof |
US6399084B1 (en) | 2001-03-05 | 2002-06-04 | Humanetics Corporation | Method for diminishing wrinkles and fine lines of the skin by the topical application of Δ5-androstene-3β-ol-7, 17 dione and metabolizable precursors thereof |
US6465446B1 (en) | 2001-03-12 | 2002-10-15 | John C. Dykstra | Treatment of dermatitis by the topical application of Δ5-androstene-3β-ol-7,17 dione and metabolizable precursors thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3107256A (en) * | 1961-09-20 | 1963-10-15 | Chemetron Corp | 16-trifluoroacetyl derivatives of 5-androsten-3beta-ol-17-one |
US4628052A (en) * | 1985-05-28 | 1986-12-09 | Peat Raymond F | Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities |
US4812447A (en) * | 1985-10-22 | 1989-03-14 | City Of Hope | Method for the treatment of nervous system degeneration |
US5292730A (en) * | 1990-08-29 | 1994-03-08 | Humanetics Corporation | Modulation of immune system with Δ5-androstenes |
JPH09151197A (ja) * | 1995-11-29 | 1997-06-10 | L T T Kenkyusho:Kk | 自己免疫疾患治療薬 |
-
1998
- 1998-11-17 AU AU14142/99A patent/AU766908B2/en not_active Ceased
- 1998-11-17 EP EP98958020A patent/EP1032266A4/de not_active Withdrawn
- 1998-11-17 WO PCT/US1998/024458 patent/WO1999025192A1/en not_active Application Discontinuation
- 1998-11-17 CA CA002311471A patent/CA2311471A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3107256A (en) * | 1961-09-20 | 1963-10-15 | Chemetron Corp | 16-trifluoroacetyl derivatives of 5-androsten-3beta-ol-17-one |
US4628052A (en) * | 1985-05-28 | 1986-12-09 | Peat Raymond F | Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities |
US4812447A (en) * | 1985-10-22 | 1989-03-14 | City Of Hope | Method for the treatment of nervous system degeneration |
US5292730A (en) * | 1990-08-29 | 1994-03-08 | Humanetics Corporation | Modulation of immune system with Δ5-androstenes |
JPH09151197A (ja) * | 1995-11-29 | 1997-06-10 | L T T Kenkyusho:Kk | 自己免疫疾患治療薬 |
Non-Patent Citations (2)
Title |
---|
PATENT ABSTRACTS OF JAPAN vol. 1997, no. 10 31 October 1997 (1997-10-31) * |
See also references of WO9925192A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2311471A1 (en) | 1999-05-27 |
AU1414299A (en) | 1999-06-07 |
EP1032266A1 (de) | 2000-09-06 |
AU766908B2 (en) | 2003-10-23 |
WO1999025192A1 (en) | 1999-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA987839B (en) | Combination therapy. | |
HUP9900163A2 (en) | Process for the preparation of sterol-and stanol-esters, and use thereof | |
ZA987843B (en) | Combination therapy. | |
HUP0001603A3 (en) | Cycloalkylalkanecarboxamides and the production and use thereof | |
AU2418499A (en) | Org-5222 in the treatment of depression | |
IL142778A0 (en) | Therapeutic product and its use | |
ZA978640B (en) | Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis. | |
GB9714971D0 (en) | Assays,therapeutic methods and means | |
GB9815312D0 (en) | Biomas treatment | |
GB9705200D0 (en) | Well treatment with particles | |
ZA973843B (en) | Treatment of asthma with TNFR-lg. | |
EP1032266A4 (de) | Verwendung von delta-5-androsten-3-beta-ol-7,17-dion in der behandlung der arthritis | |
GB0103210D0 (en) | Materials treatment | |
GB9726223D0 (en) | The treatment of materials | |
GB9609944D0 (en) | An improvement in the treatment of wastes | |
GB9811525D0 (en) | Sewage treatment | |
AU3061199A (en) | Skin treatment compositions and the use thereof | |
GB9810920D0 (en) | Therapeutic use | |
GB9818524D0 (en) | Inorgasmia treatment | |
GB9815497D0 (en) | Treatment | |
GB9707104D0 (en) | An improvement in the treatment of bio-waste | |
AU6409598A (en) | An improvement in the treatment of wastes | |
ZA991021B (en) | Benzofuran-4-carboxamides and their therapeutic use. | |
GB9828550D0 (en) | Treatment | |
ZA9711116B (en) | The treatment of materials. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000526 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030603 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20060601 |